Researchers were able to dissect the immune response leading to successful recovery from COVID-19, which might be the secret to finding an effective vaccine. Image: Doherty Institute
Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection.
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) – a joint venture between the University of Melbourne and the Royal Melbourne hospital – were able to test blood samples at four different time points in an otherwise healthy woman in her 40s, who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.
Published today in Nature Medicine is a detailed report of how the patient’s immune system responded to the virus. One of the authors on the paper, research fellow Dr Oanh Nguyen said this was the first time that broad immune responses to COVID-19 have been reported.
“We looked at the whole breadth of the immune response in this patient using the knowledge we have built over many years of looking at immune responses in patients hospitalised with influenza,” Dr Nguyen said.
“Three days after the patient was admitted, we saw large populations of several immune cells, which are often a tell-tale sign of recovery during seasonal influenza infection, so we predicted that the patient would recover in three days, which is what happened.”
The research team was able to do this research so rapidly thanks to SETREP-ID (Sentinel Travellers and Research Preparedness for Emerging Infectious Disease), led by Royal Melbourne Hospital Infectious Diseases Physician Dr Irani Thevarajan at the Doherty Institute.
SETREP-ID is a platform that enables a broad range of biological sampling to take place in returned travellers in the event of a new and unexpected infectious disease outbreak, which is exactly how COVID-19 started in Australia.
“When COVID-19 emerged, we already had ethics and protocols in place so we could rapidly start looking at the virus and immune system in great detail,” Dr Thevarajan said.
“Already established at a number of Melbourne hospitals, we now plan to roll out SETREP-ID as a national study.”
Working together with University of Melbourne Professor Katherine Kedzierska, a laboratory head at the Doherty Institute and a world-leading influenza immunology researcher, the team were able to dissect the immune response leading to successful recovery from COVID-19, which might be the secret to finding an effective vaccine.
“We showed that even though COVID-19 is caused by a new virus, in an otherwise healthy person, a robust immune response across different cell types was associated with clinical recovery, similar to what we see in influenza,” Professor Kedzierska said.
“This is an incredible step forward in understanding what drives recovery of COVID-19. People can use our methods to understand the immune responses in larger COVID-19 cohorts, and also understand what’s lacking in those who have fatal outcomes.”
Dr Thevarajan said that current estimates show more than 80 per cent of COVID-19 cases are mild-to-moderate, and understanding the immune response in these mild cases is very important research.
“We hope to now expand our work nationally and internationally to understand why some people die from COVID-19, and build further knowledge to assist in the rapid response of COVID-19 and future emerging viruses,” she said.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- COVID-19 pandemic amplifying voter disenfranchisementon October 7, 2020 at 3:23 am
Public health leaders agree that voting by mail is the safest way to minimize the risk of COVID-19 infection. Last month, Pérez discussed voter safety and the challenges of mail-in voting in an ...
- What Apple, President Trump and COVID-19 Have In Commonon October 7, 2020 at 3:13 am
Trump, COVID-19, and Apple. These three popular topics of conversation do not seem to have much in common, but they teach a valuable lesson about what to expect of a stock in the short term.
- Thousands of sick prisoners sought release as Covid-19 spread. Nearly all were denied.on October 7, 2020 at 3:06 am
As the pandemic ramped up, federal prison wardens denied or ignored more than 98 percent of compassionate release requests, newly obtained data shows.
- Column: Why are Trump and Republicans the ones getting COVID-19? Must be a liberal conspiracy.on October 7, 2020 at 3:06 am
I don’t mean to sound conspiratorial, but I think godless DEMONcrats infected President Trump, Republican senators and other leaders with COVID-19.
- Should a condo association prohibit pool use because of covid-19?on October 7, 2020 at 3:03 am
How do I get our homeowners association board to open up our building’s three pools, all of which have been closed since March due to the pandemic? The board members say they are concerned that if ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Covid-19 immune system response
- Promising Research Showing New Way To Treat And Stop The Spread Of COVID-19 Using Gene Silencing And Reactivation Of "Innate" Immune Systemon October 6, 2020 at 10:03 am
"SIREN technology offers a novel treatment for the control of COVID-19 by both stopping the replication of the virus and preventing the virus from suppressing immune system components in the first ...
- Infectious Disease Research Institute's Immune-Enhancing Technologies Are Driving Progress Toward Multiple COVID-19 Vaccines and Therapieson October 6, 2020 at 9:00 am
PRNewswire/ -- The Infectious Disease Research Institute (IDRI) is advancing several COVID-19 therapies and vaccines after spending nearly three ...
- COVID-19 outcomes in patients with rare inborn immune disorderson October 6, 2020 at 5:11 am
A new research report reveals that 94 individuals with rare inherited immune disorders, otherwise known as primary immunodeficiency (PID), who were infected with the SARS-CoV-2 coronavirus had similar ...
- Charting a Covid-19 Immune Responseon October 5, 2020 at 2:14 pm
The coronavirus can be a tricky adversary — and for many people whose cases of Covid-19 are severe, the greatest threat to survival might not be the pathogen itself, but the deadly forces that the ...
- Trump's Covid-19 Treatment Seeks to Boost Immune Responseon October 5, 2020 at 8:10 am
The experimental infusion doctors have given to President Trump seeks to counter a problem affecting many older Covid-19 patients: an ineffective immune response. Among other treatments, Mr. Trump has ...